Key result
Severe autonomic neuropathy prevents HF symptoms in cardiac amyloidosis by blunting sympathetic activation.
Why the study?
The essential role of sympathetic activation and venous tone in the development of congestive heart failure syndrome remains unclear despite severe cardiac amyloidosis.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
May mask heart failure symptoms in cardiac amyloidosis; hypothesis-generating case requiring prospective validation.
Heart failure is a complex clinical syndrome that requires the interaction of many organ systems for its development, including the heart, renal, and neuroendocrine systems. The heart may be severely abnormal yet symptoms of heart failure may not develop. The present case illustrates, by its absence, the essential role of neuroendocrine sympathetic activation and venous tone in the development of the congestive heart failure syndrome. A 66-year-old man with primary light-chain (AL) amyloidosis was referred to our hospital for management and evaluation. He had an immunoglobulin G kappa spike in his serum, nephrotic range proteinuria, and kidney biopsy confirmed the diagnosis of amyloidosis. He complained of progressive fatigue, dizziness, and episodes of recurrent syncope and orthostatic hypotension for approximately 4 months. He denied chest pain, shortness of breath, orthopnea, or paroxysmal nocturnal dyspnea. He had been maintained on salt pills, fludrocortisone, and midodrine for orthostatic hypotension. Other medications included pyridostigmine, paroxetine, finasteride, atorvastatin, and potassium chloride. Medical history included prostatic hypertrophy, hyperlipidemia, hypertension, anxiety, bilateral hip replacements, knee replacement, and uvulectomy. There was no family history of amyloid disease. On examination his blood pressure was 90/60 mm Hg with a heart rate of 84 beats per minute while supine, and a blood pressure of 60/40 mm Hg while upright. The patient had no jugular venous distention. Cardiovascular examination showed distant heart sounds, without murmurs, rubs, or gallops. The lungs were clear. There was no organomegaly and no peripheral edema. The patient's gait was unsteady and he used a wheelchair for ambulation. Laboratory results were significant for hematocrit of 41%, creatinine of 0.5 mg/dL, nephrotic range proteinuria of 6.9 g/24 h, total protein of 3.9 g/dL, albumin of 1.9 g/dL, and cholesterol of 352 mg/dL. His electrocardiogram demonstrated a normal sinus rhythm with low limb lead voltage consistent with amyloid cardiomyopathy (Figure 1). Chest x-ray demonstrated small pleural effusions without pulmonary vascular congestion. Echocardiography (Figure 1) demonstrated a left ventricular end diastolic dimension of 4.2 cm with an end systolic dimension of 3.1 cm. Left atrial size was 4.9 cm. Ejection fraction was 45% to 50%. The left ventricle showed severe concentric hypertrophy. Both septal wall thickness and posterior wall thickness were 2 cm. The right ventricle was thickened with normal function. There was trace pericardial effusion. The mitral pulse wave Doppler inflow pattern was consistent with impaired relaxation (grade I diastolic dysfunction). The tissue Doppler of the mitral valve annulus showed an E′ of 3.8 cm/s and an A′ of 7.85 cm/s. Abdominal ultrasound did not demonstrate hepatomegaly or splenomegaly. Twelve-lead electrocardiogram (upper left), short-axis echocardiographic image (upper right), parasternal long-axis image (lower left), and mitral Doppler inflow profile (lower right). Further evaluation included a right heart catheterization with biopsy. Cardiac biopsy confirmed primary amyloidosis with cardiac involvement. Biopsy showed diffuse interstitial amyloid wrapped around individual myocytes (Figure 2). The Congo red stain showed typical apple-green birefringence when viewed under polarized light (Figure 2). Immunohistochemical staining was positive for kappa light chain and negative for lambda. Right atrial pressure was 2 mm Hg. Right ventricular pressure was 17/2 mm Hg. Pulmonary artery pressure was 23/16 mm Hg and saturation was 68%. Wedge pressure was 4 mm Hg with a cardiac output of 4.2 L/min. Biopsy from our patient showing diffuse interstitial amyloid wrapped around myocytes (hematoxylin and eosin stain) (top). Congo red stain showing typical apple-green birefringence with polarized light (bottom). Because our patient had significant symptomatic orthostatic hypotension and syncope suggestive of autonomic nervous system disease, he underwent neurophysiological testing. Sympathetic and parasympathetic evaluation showed abnormally low heart rate variability at rest and with deep breathing. His consecutive R-R interval mean difference was severely reduced both at rest, 5.2±4.7 ms (normal >14 ms), and with deep breathing, 6.4±6.6 ms (normal >17 ms). During Valsalva maneuver the heart rate increase was abnormally low with an average ratio of pre-/post-Valsalva of 1.03 (normal >1.35). During tilt table testing, the patient's blood pressure fell from 137/80 mm Hg (87 beats per minute) at zero degrees to 50/35 mm Hg (94 beats per minute) at 2 minutes of 70° head up tilt with symptomatic presyncope, indicating severe orthostatic hypotension. Sudomotor testing of sympathetic skin responses showed no evoked amplitude response to electrical stimulation, cough, or gasp at any of the 4 extremities. The results of neurophysiologic testing were consistent with an autonomic neuropathy. Though systolic and diastolic dysfunction are 2 pathophysiologic mechanisms that may lead to the heart failure syndrome, elevated atrial pressures and symptoms of heart failure are not guaranteed by their presence. Symptoms of congestive heart failure depend upon a complex cascade of physiologic mechanisms upstream and downstream of the heart, including interaction of the vascular, renal, and neurohormonal systems under the control of the autonomic nervous system. Our patient had advanced, biopsy-proven cardiac amyloidosis yet he did not exhibit symptoms or signs of heart failure typical of a patient with severe cardiac amyloid disease.1,2 Specifically, he did not have shortness of breath at rest or with exertion, nor did he experience orthopnea or paroxysmal nocturnal dyspnea. His measured intracardiac pressures, including pulmonary capillary wedge pressure at rest, were within normal limits. Given evidence of extensive cardiac infiltration by amyloid on his cardiac biopsy, coupled with the electrocardiographic findings of low limb voltage and right axis deviation, echocardiographic findings of severe concentric left ventricular hypertrophy and Doppler evidence of diastolic dysfunction, the presence of elevated atrial pressures and heart failure symptoms would certainly be expected. Renal infiltration by amyloid led to his nephrotic syndrome with low total serum protein and albumin, resulting in low serum oncotic pressure, which should promote the development of pulmonary edema by reducing the degree of elevation of pulmonary wedge pressure required to cause pulmonary edema.3 However, because of severe autonomic system amyloidosis that reduced sympathetic control, as documented by neurophysiologic testing, our patient had an inability to maintain vascular, and particularly venous, tone resulting in reduced intracardiac filling pressures and absence of heart failure symptoms, as well as recurrent syncope. Evidence of impaired relaxation on Doppler inflow pattern may thus underestimate the true degree of diastolic dysfunction in this patient as further grades of diastolic dysfunction (ie, pseudonormalization and restrictive filling pattern) require elevated filling pressures, which this patient could not have because of his autonomic neuropathy. The role of the sympathetic nervous system in heart failure has been well established. Most heart failure patients demonstrate an abnormally activated sympathetic nervous system.4 Sympathetic activation, increased venous tone and a central shift of blood volume are triggered by decreasing cardiac output relative to metabolic demand. These lead to increased left ventricular preload and increased pulmonary wedge pressure. A significant portion (∼70%–80%) of the total blood volume in normal individuals is in the venous circulation, which is comprised of both stressed and unstressed volumes. A shift of some of this latter volume towards the central circulation is required to increase filling pressures to those characteristic of heart failure.5 Thus, the ventricle, in relation to filling, should be viewed as essentially passive—its loading (filling) pressures being determined by the venous vascular system and not by the ventricle itself.5 Arterial vasoconstriction may lead to further decline in cardiac output by increasing load. Renal sympathetic activity leads to salt/fluid retention and increased heart failure symptoms through the renin-angiotensin-aldosterone pathway.4 The sympathetic nervous system has been implicated in both acute and chronic elevation of intracardiac pressures. Theoretic analysis has shown that elevation of pulmonary wedge pressure in acute heart failure is dependent on an intact sympathetic nervous system.5 Long-term elevation of loading conditions requires chronically increased venous tone. Mean circulatory pressure has been found to be higher in patients with chronic heart failure than in patients without heart failure.6 Also, sympathetic ganglionic blockers have been shown to produce a greater reduction in venous pressure in patients with heart failure than in patients without heart failure,6 implying sympathetic activation. Elevated venous tone and chronically elevated preload leads to ventricular remodeling and hypertrophy.7 The beneficial effects of treatments employing preload reduction strategies, such as nitrates, diuretics, renin-angiotensin and aldosterone inhibitors, and ventricular assist devices, further highlight the importance of loading conditions and especially preload, to the heart failure syndrome. Involvement of both the somatic and the autonomic nervous system is common in primary amyloidosis, and symptoms of neuropathy are presenting symptoms in about a fifth of cases.8 Autonomic neuropathy, which was so prominent to our patient's presentation, occurs in up to a quarter of patients with primary amyloidosis.9 Common manifestations of amyloid autonomic dysfunction include orthostatic hypotension, urinary retention, and urinary/fecal incontinence.8 Other autonomic disturbances include abnormalities in heart rate variability and modulation of heart rate, blood pressure, and baroreflex function.9 Amyloidosis has also been shown to involve the cardiac conduction system and aortocoronary neuroreceptors.10 Our patient did not exhibit symptoms of heart failure despite having a severely hypertrophied heart with evidence of diastolic dysfunction secondary to amyloid infiltration. His severe autonomic neuropathy prevented sympathetic activation required for elevation of central venous pressure and development of congestive symptoms. An intact sympathetic nervous system and maintenance of venous tone are not only essential for normal cardiovascular function, but are required for the development of the signs and symptoms of congestive heart failure. This patient's clinical presentation strongly suggests that the reduction of neurohormonal activation is a vital therapeutic objective when treating congestive heart failure.
No takes yet. Share an insight, caveat, or question.
Abramov et al. (2009) conducted a case report in Primary light-chain (AL) amyloidosis (n=1). Severe autonomic neuropathy was evaluated on Development of congestive heart failure symptoms. A 66-year-old man with severe cardiac amyloidosis did not develop congestive heart failure symptoms due to severe autonomic neuropathy preventing sympathetic activation and venous tone maintenance.
Synapse has enriched 10 related papers. Consider them for comparative context: